Day One Announces Two New Appointments to Board of Directors
BRISBANE, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a clinical-stage […]
Quanta and Ambarella Expand Strategic Partnership to Innovate Broader Range of Cutting-Edge AI Solutions
TAOYUAN CITY, Taiwan and SANTA CLARA, Calif., Jan. 11, 2024 (GLOBE NEWSWIRE) — Quanta Computer Inc., a trailblazer in advanced […]
Crinetics Pharmaceuticals Announces January 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Jan. 10, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2024, […]
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
EMERYVILLE, Calif., Jan. 10, 2024 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to […]
Praxis Precision Medicines, Inc. Announces Proposed Public Offering
BOSTON, Jan. 10, 2024 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights […]
UPDATE — HBT Financial, Inc. to Announce Fourth Quarter 2023 Financial Results on January 24, 2024
BLOOMINGTON, Ill., Jan. 10, 2024 (GLOBE NEWSWIRE) — HBT Financial, Inc. (NASDAQ: HBT) (the “Company” or “HBT”), the holding company […]
TrustCo to Release Fourth Quarter 2023 Results on January 22, 2024; Conference Call on January 23, 2024
GLENVILLE, N.Y., Jan. 10, 2024 (GLOBE NEWSWIRE) — TrustCo Bank Corp NY (TrustCo, Nasdaq: TRST) today announced that it will […]
Dime Announces Continued Partnership for the Dime McCarren 5K in 2024
HAUPPAUGE, N.Y., Jan. 10, 2024 (GLOBE NEWSWIRE) — Dime Community Bancshares, Inc. (Nasdaq: DCOM and DCOMP) (the “Company”) announced that […]
Vicor to participate in 26th Annual Needham Growth Conference
ANDOVER, Mass., Jan. 10, 2024 (GLOBE NEWSWIRE) — Vicor (Nasdaq: VICR) today announced that Patrizio Vinciarelli, CEO, Phil Davies, Global VP of […]
BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K
NEW YORK, Jan. 10, 2024 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical […]
